| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.007 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.087 | 0.009 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.18 | 0.009 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |